Develops accessible, affordable cancer screening and monitoring using routine blood tests to identify genetic tumor biomarkers
Develops accessible, affordable cancer screening and monitoring using routine blood tests to identify genetic tumor biomarkers. The company aims to integrate tumor genomic testing into standard checkups and provide preemptive, preventive, and follow-up screening for common and rare cancers, using existing laboratory equipment and know-how. Products are in R&D.